Roche revs up new launches—and a slew of data readouts—as it emerges from the biosim trough
Roche revs up new launches—and a slew of data readouts—as [...]
Humira rings up $20.7B in 2021, but AbbVie still mum on post-biosimilar expectations
Humira rings up $20.7B in 2021, but AbbVie still mum [...]
DHL earmarks $400M to expand its pharma, medical device supply chain network this year
DHL earmarks $400M to expand its pharma, medical device supply [...]
Novartis says Leqvio launch will feature a ‘modest initial ramp,’ but blockbuster potential awaits
Novartis says Leqvio launch will feature a ‘modest initial ramp,’ [...]
GlaxoSmithKline’s HIV drug Cabenuva scores FDA nod for 2-month dosing
GlaxoSmithKline’s HIV drug Cabenuva scores FDA nod for 2-month dosing [...]
Novartis’ Sandoz reportedly the target of $25B buyout bid from Carlyle and Blackstone
Novartis’ Sandoz reportedly the target of $25B buyout bid from [...]
Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig
Novartis, Amgen settle their dueling lawsuits over migraine drug Aimovig [...]
Two Biogen board members depart as company struggles to get Aduhelm off the ground
Two Biogen board members depart as company struggles to get [...]
Roche, with an FDA nod for Vabysmo in hand, looks to challenge Regeneron’s dominant Eylea
Roche, with an FDA nod for Vabysmo in hand, looks [...]
FDA issues 3 observations to Granules India site in US after pre-approval inspection
FDA issues 3 observations to Granules India site in US [...]